Zur Rose Group AG
A European e-commerce pharmacy providing an online platform for medicines and health.
ROSE | SW
Overview
Corporate Details
- ISIN(s):
- CH0042615283 (+1 more)
- LEI:
- 50670038OH136R5Z4663
- Country:
- Switzerland
- Address:
- Walzmühlestrasse 49, 8500 Frauenfeld
- Sector:
- Wholesale and retail trade
Description
DocMorris AG, formerly Zur Rose Group AG, is a leading European e-commerce pharmacy. The company provides an online platform for medicines and develops digital health services. Its core strategy involves creating a comprehensive digital health ecosystem that connects patients, doctors, pharmacies, and health insurers on a single platform. The company's vision is to enable individuals to manage their health with a single click, offering integrated care and treatment solutions. Originally founded as a pharmacy wholesaler, it has evolved to focus on the digitalization of healthcare services.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-12-01 00:00 |
Terms of Reference of the Compensation and Nomination Committee
|
English | 342.3 KB | ||
| 2023-12-01 00:00 |
Terms of Reference of the Audit Committee
|
English | 707.4 KB | ||
| 2023-12-01 00:00 |
Reglement für den Prüfungsausschuss
|
German | 799.1 KB | ||
| 2023-11-22 07:37 |
DocMorris optimises organisational structure and prepares for e-prescription gr…
|
English | 8.4 KB | ||
| 2023-11-22 01:00 |
DocMorris optimises organisational structure and prepares for e-prescription gr…
|
English | 7.5 KB | ||
| 2023-11-22 01:00 |
DocMorris AG: DocMorris optimiert Organisationsstruktur und stellt sich für E-R…
|
German | 8.3 KB | ||
| 2023-11-07 00:00 |
Organisationsreglement
|
German | 2.5 MB | ||
| 2023-10-19 06:58 |
DocMorris strengthens path to profitable growth in third quarter; slightly redu…
|
English | 24.6 KB | ||
| 2023-10-19 02:00 |
DocMorris strengthens path to profitable growth in third quarter; slightly redu…
|
English | 19.9 KB | ||
| 2023-10-19 02:00 |
DocMorris festigt im dritten Quartal den Pfad zu profitablem Wachstum; leicht r…
|
German | 20.6 KB | ||
| 2023-08-17 06:57 |
DocMorris: Solid basis for sustainable, profitable growth
|
English | 33.5 KB | ||
| 2023-08-17 02:00 |
DocMorris: Solid basis for sustainable, profitable growth
|
English | 27.4 KB | ||
| 2023-08-17 02:00 |
DocMorris: Gefestigte Basis für nachhaltiges, profitables Wachstum
|
German | 28.3 KB | ||
| 2023-08-17 00:00 |
Half-Year Results Presentation 2023
|
English | 1.2 MB | ||
| 2023-08-17 00:00 |
Halbjahresergebnis-Präsentation 2023 (englisch)
|
English | 1.2 MB |
Automate Your Workflow. Get a real-time feed of all Zur Rose Group AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Zur Rose Group AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Zur Rose Group AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-20 | N/A | Non-Executive member | Buy | None | 175,188.00 CHF |
| 2025-05-20 | N/A | Non-Executive member | Buy | None | 28,818.00 CHF |
| 2025-05-19 | N/A | Executive member | Buy | None | 34,500.00 CHF |
| 2025-05-19 | N/A | Non-Executive member | Buy | None | 14,040.00 CHF |
| 2025-05-19 | N/A | Executive member | Buy | None | 9,142.50 CHF |
| 2025-05-16 | N/A | Non-Executive member | Buy | None | 1,035,000.00 CHF |
| 2025-05-16 | N/A | Executive member | Buy | None | 46,400.00 CHF |
| 2025-05-16 | N/A | Executive member | Buy | None | 10,315.50 CHF |
| 2025-05-16 | N/A | Non-Executive member | Buy | None | 8,616.00 CHF |
| 2025-05-15 | N/A | Executive member | Buy | None | 678,770.25 CHF |
Peer Companies
